Cencora Insider Trades: Quiet Portfolio Moves, No Sign of Weakness
Investor insights: Cencora insider Greenberg sells 1,280 shares—routine, low‑impact move reflecting portfolio management, not a warning to investors.
3 minutes to read
CENCORA INC
Cencora Board Member Nally Dennis M Buys 113 Shares, Signaling Steady Insider Confidence Amid Modest Volatility
Insider buying of Cencora shares signals board confidence and a potential rebound for the healthcare provider, offering investors a bullish outlook.
3 minutes to read
Cencora Insider Buying: Director Tyler Lauren M’s 550‑Share Purchase Signals Long‑Term Confidence Amid Volatile Market Gains
Insider buying by Tyler Lauren M shows steady confidence in Cencora’s growth, suggesting potential upside for long‑term investors.
3 minutes to read
Cencora Insider Buys 4,000 Shares, Signaling Confidence Amid Market Volatility
Insider buying by Cencora’s Durcan Dermot Mark signals confidence amid volatility, boosting investor confidence in its federal contracts and earnings potential.
3 minutes to read
Cencora Insider Buys Signal Confidence Amid CFO Transition — Senior Shareholders Accumulate as Stock Holds Steady
Insider buying at Cencora shows confidence, not panic—Durcan Dermot Mark’s 4,000‑share purchase signals long‑term conviction and potential upside.
3 minutes to read
Cencora CEO Sells Shares Just After $3.5 B Merger Announcement – Routine Move or Signal?
CEO Robert Mauch sells 1,333 shares of Cencora stock a day after the $3.5 B Covetrus merger, indicating routine liquidity management amid a promising veterinary tech expansion.
3 minutes to read
Battaglia Silvana’s Small Buy Signals Big Confidence in Cencora as Stock Skims 52‑Week High
Insider buying by Cencora’s executive Silvana signals confidence in the firm’s rebound, amid high P/E, positive sentiment and a near‑peak stock price.
3 minutes to read